Posted in | News | Nanobusiness

NaturalNano Announces Completion of Business

NaturalNano, Inc. (OTC Bulletin Board: NNAN)(FWB: N3N) Acting CEO and President James Wemett announced today that he has recently completed a review of the NaturalNano business including the core technology, patent portfolio, current and potential customers. Mr. Wemett has confirmed both the technical and commercial viability of NaturalNano's additive technologies and processes, including its proprietary Pleximer(TM) polymer additive. The extensive review was conducted through a series of meetings and conferences with the Company's technical team, key customers, suppliers and potential strategic partners.

Mr. Wemett said that "I am encouraged by this bottom up review and am particularly encouraged by the response from the customer base. NaturalNano is actively engaged with its commercial partners on a number of feasibility studies and are in discussions on strategic longer term relationships. We continue to fulfill existing contractual obligations while we aggressively seek additional financially attractive opportunities to commercialize our proprietary technology. As we go forward, I will be informing our investors, and the financial community at large, of these exciting plans as well as the continued strengthening of the new management team."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.